0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Procaine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-6U8513
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Procaine Market Insights Forecast to 2028
BUY CHAPTERS

Procaine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6U8513
Report
November 2024
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Procaine - Market Size

The global market for Procaine was estimated to be worth US$ 1569 million in 2023 and is forecast to a readjusted size of US$ 2203.1 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Procaine - Market

Procaine - Market

Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it is also used in dentistry. Owing to the ubiquity of the trade name Novocain, in some regions, procaine is referred to generically as novocaine. It acts mainly as a sodium channel blocker. Today it is used therapeutically in some countries due to its sympatholytic, anti-inflammatory, perfusion-enhancing, and mood-enhancing effects
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Procaine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Procaine by region & country, by Type, and by Application.
The Procaine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procaine.
Market Segmentation

Scope of Procaine - Market Report

Report Metric Details
Report Name Procaine - Market
Forecasted market size in 2030 US$ 2203.1 million
CAGR 5.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Injection
  • Powder
Segment by Application
  • Hospital
  • Drug Store
  • On-line
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly and Company, Consolidated Pharmaceutical, Pfizer, Bristol-Myers Squibb, Bel Mar Laboratories, Elkins Sinn, Bayer, Watson Laboratories, RNP Pharmaceuticals, Tbilchempharma, SÜDmedica Gmbh, Grindeks, Towa Yakuhin, Hikari Seiyaku, Köhler-Pharma, Ardeapharma, Stada, Fuso Pharmaceutical, Hevert-Arzneimittel, Teofarma, Richter Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Procaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Procaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Procaine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Procaine - Market size in 2030?

Ans: The Procaine - Market size in 2030 will be US$ 2203.1 million.

Who are the main players in the Procaine - Market report?

Ans: The main players in the Procaine - Market are Eli Lilly and Company, Consolidated Pharmaceutical, Pfizer, Bristol-Myers Squibb, Bel Mar Laboratories, Elkins Sinn, Bayer, Watson Laboratories, RNP Pharmaceuticals, Tbilchempharma, SÜDmedica Gmbh, Grindeks, Towa Yakuhin, Hikari Seiyaku, Köhler-Pharma, Ardeapharma, Stada, Fuso Pharmaceutical, Hevert-Arzneimittel, Teofarma, Richter Pharma

What are the Application segmentation covered in the Procaine - Market report?

Ans: The Applications covered in the Procaine - Market report are Hospital, Drug Store, On-line

What are the Type segmentation covered in the Procaine - Market report?

Ans: The Types covered in the Procaine - Market report are Injection, Powder

1 Market Overview
1.1 Procaine Product Introduction
1.2 Global Procaine Market Size Forecast
1.2.1 Global Procaine Sales Value (2019-2030)
1.2.2 Global Procaine Sales Volume (2019-2030)
1.2.3 Global Procaine Sales Price (2019-2030)
1.3 Procaine Market Trends & Drivers
1.3.1 Procaine Industry Trends
1.3.2 Procaine Market Drivers & Opportunity
1.3.3 Procaine Market Challenges
1.3.4 Procaine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Procaine Players Revenue Ranking (2023)
2.2 Global Procaine Revenue by Company (2019-2024)
2.3 Global Procaine Players Sales Volume Ranking (2023)
2.4 Global Procaine Sales Volume by Company Players (2019-2024)
2.5 Global Procaine Average Price by Company (2019-2024)
2.6 Key Manufacturers Procaine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Procaine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Procaine
2.9 Procaine Market Competitive Analysis
2.9.1 Procaine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Procaine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procaine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Injection
3.1.2 Powder
3.2 Global Procaine Sales Value by Type
3.2.1 Global Procaine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Procaine Sales Value, by Type (2019-2030)
3.2.3 Global Procaine Sales Value, by Type (%) (2019-2030)
3.3 Global Procaine Sales Volume by Type
3.3.1 Global Procaine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Procaine Sales Volume, by Type (2019-2030)
3.3.3 Global Procaine Sales Volume, by Type (%) (2019-2030)
3.4 Global Procaine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 On-line
4.2 Global Procaine Sales Value by Application
4.2.1 Global Procaine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Procaine Sales Value, by Application (2019-2030)
4.2.3 Global Procaine Sales Value, by Application (%) (2019-2030)
4.3 Global Procaine Sales Volume by Application
4.3.1 Global Procaine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Procaine Sales Volume, by Application (2019-2030)
4.3.3 Global Procaine Sales Volume, by Application (%) (2019-2030)
4.4 Global Procaine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Procaine Sales Value by Region
5.1.1 Global Procaine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Procaine Sales Value by Region (2019-2024)
5.1.3 Global Procaine Sales Value by Region (2025-2030)
5.1.4 Global Procaine Sales Value by Region (%), (2019-2030)
5.2 Global Procaine Sales Volume by Region
5.2.1 Global Procaine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Procaine Sales Volume by Region (2019-2024)
5.2.3 Global Procaine Sales Volume by Region (2025-2030)
5.2.4 Global Procaine Sales Volume by Region (%), (2019-2030)
5.3 Global Procaine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Procaine Sales Value, 2019-2030
5.4.2 North America Procaine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Procaine Sales Value, 2019-2030
5.5.2 Europe Procaine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Procaine Sales Value, 2019-2030
5.6.2 Asia Pacific Procaine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Procaine Sales Value, 2019-2030
5.7.2 South America Procaine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Procaine Sales Value, 2019-2030
5.8.2 Middle East & Africa Procaine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Procaine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Procaine Sales Value
6.2.1 Key Countries/Regions Procaine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Procaine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Procaine Sales Value, 2019-2030
6.3.2 United States Procaine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Procaine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Procaine Sales Value, 2019-2030
6.4.2 Europe Procaine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Procaine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Procaine Sales Value, 2019-2030
6.5.2 China Procaine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Procaine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Procaine Sales Value, 2019-2030
6.6.2 Japan Procaine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Procaine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Procaine Sales Value, 2019-2030
6.7.2 South Korea Procaine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Procaine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Procaine Sales Value, 2019-2030
6.8.2 Southeast Asia Procaine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Procaine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Procaine Sales Value, 2019-2030
6.9.2 India Procaine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Procaine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Company Information
7.1.2 Eli Lilly and Company Introduction and Business Overview
7.1.3 Eli Lilly and Company Procaine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eli Lilly and Company Procaine Product Offerings
7.1.5 Eli Lilly and Company Recent Development
7.2 Consolidated Pharmaceutical
7.2.1 Consolidated Pharmaceutical Company Information
7.2.2 Consolidated Pharmaceutical Introduction and Business Overview
7.2.3 Consolidated Pharmaceutical Procaine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Consolidated Pharmaceutical Procaine Product Offerings
7.2.5 Consolidated Pharmaceutical Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Procaine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Procaine Product Offerings
7.3.5 Pfizer Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Information
7.4.2 Bristol-Myers Squibb Introduction and Business Overview
7.4.3 Bristol-Myers Squibb Procaine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bristol-Myers Squibb Procaine Product Offerings
7.4.5 Bristol-Myers Squibb Recent Development
7.5 Bel Mar Laboratories
7.5.1 Bel Mar Laboratories Company Information
7.5.2 Bel Mar Laboratories Introduction and Business Overview
7.5.3 Bel Mar Laboratories Procaine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bel Mar Laboratories Procaine Product Offerings
7.5.5 Bel Mar Laboratories Recent Development
7.6 Elkins Sinn
7.6.1 Elkins Sinn Company Information
7.6.2 Elkins Sinn Introduction and Business Overview
7.6.3 Elkins Sinn Procaine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Elkins Sinn Procaine Product Offerings
7.6.5 Elkins Sinn Recent Development
7.7 Bayer
7.7.1 Bayer Company Information
7.7.2 Bayer Introduction and Business Overview
7.7.3 Bayer Procaine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bayer Procaine Product Offerings
7.7.5 Bayer Recent Development
7.8 Watson Laboratories
7.8.1 Watson Laboratories Company Information
7.8.2 Watson Laboratories Introduction and Business Overview
7.8.3 Watson Laboratories Procaine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Watson Laboratories Procaine Product Offerings
7.8.5 Watson Laboratories Recent Development
7.9 RNP Pharmaceuticals
7.9.1 RNP Pharmaceuticals Company Information
7.9.2 RNP Pharmaceuticals Introduction and Business Overview
7.9.3 RNP Pharmaceuticals Procaine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 RNP Pharmaceuticals Procaine Product Offerings
7.9.5 RNP Pharmaceuticals Recent Development
7.10 Tbilchempharma
7.10.1 Tbilchempharma Company Information
7.10.2 Tbilchempharma Introduction and Business Overview
7.10.3 Tbilchempharma Procaine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tbilchempharma Procaine Product Offerings
7.10.5 Tbilchempharma Recent Development
7.11 SÜDmedica Gmbh
7.11.1 SÜDmedica Gmbh Company Information
7.11.2 SÜDmedica Gmbh Introduction and Business Overview
7.11.3 SÜDmedica Gmbh Procaine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SÜDmedica Gmbh Procaine Product Offerings
7.11.5 SÜDmedica Gmbh Recent Development
7.12 Grindeks
7.12.1 Grindeks Company Information
7.12.2 Grindeks Introduction and Business Overview
7.12.3 Grindeks Procaine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Grindeks Procaine Product Offerings
7.12.5 Grindeks Recent Development
7.13 Towa Yakuhin
7.13.1 Towa Yakuhin Company Information
7.13.2 Towa Yakuhin Introduction and Business Overview
7.13.3 Towa Yakuhin Procaine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Towa Yakuhin Procaine Product Offerings
7.13.5 Towa Yakuhin Recent Development
7.14 Hikari Seiyaku
7.14.1 Hikari Seiyaku Company Information
7.14.2 Hikari Seiyaku Introduction and Business Overview
7.14.3 Hikari Seiyaku Procaine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Hikari Seiyaku Procaine Product Offerings
7.14.5 Hikari Seiyaku Recent Development
7.15 Köhler-Pharma
7.15.1 Köhler-Pharma Company Information
7.15.2 Köhler-Pharma Introduction and Business Overview
7.15.3 Köhler-Pharma Procaine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Köhler-Pharma Procaine Product Offerings
7.15.5 Köhler-Pharma Recent Development
7.16 Ardeapharma
7.16.1 Ardeapharma Company Information
7.16.2 Ardeapharma Introduction and Business Overview
7.16.3 Ardeapharma Procaine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Ardeapharma Procaine Product Offerings
7.16.5 Ardeapharma Recent Development
7.17 Stada
7.17.1 Stada Company Information
7.17.2 Stada Introduction and Business Overview
7.17.3 Stada Procaine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Stada Procaine Product Offerings
7.17.5 Stada Recent Development
7.18 Fuso Pharmaceutical
7.18.1 Fuso Pharmaceutical Company Information
7.18.2 Fuso Pharmaceutical Introduction and Business Overview
7.18.3 Fuso Pharmaceutical Procaine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Fuso Pharmaceutical Procaine Product Offerings
7.18.5 Fuso Pharmaceutical Recent Development
7.19 Hevert-Arzneimittel
7.19.1 Hevert-Arzneimittel Company Information
7.19.2 Hevert-Arzneimittel Introduction and Business Overview
7.19.3 Hevert-Arzneimittel Procaine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Hevert-Arzneimittel Procaine Product Offerings
7.19.5 Hevert-Arzneimittel Recent Development
7.20 Teofarma
7.20.1 Teofarma Company Information
7.20.2 Teofarma Introduction and Business Overview
7.20.3 Teofarma Procaine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Teofarma Procaine Product Offerings
7.20.5 Teofarma Recent Development
7.21 Richter Pharma
7.21.1 Richter Pharma Company Information
7.21.2 Richter Pharma Introduction and Business Overview
7.21.3 Richter Pharma Procaine Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Richter Pharma Procaine Product Offerings
7.21.5 Richter Pharma Recent Development
8 Industry Chain Analysis
8.1 Procaine Industrial Chain
8.2 Procaine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Procaine Sales Model
8.5.2 Sales Channel
8.5.3 Procaine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Procaine Market Trends
    Table 2. Procaine Market Drivers & Opportunity
    Table 3. Procaine Market Challenges
    Table 4. Procaine Market Restraints
    Table 5. Global Procaine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Procaine Revenue Market Share by Company (2019-2024)
    Table 7. Global Procaine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Procaine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Procaine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Procaine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Procaine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Procaine
    Table 13. Global Procaine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procaine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Procaine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Procaine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Procaine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Procaine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Procaine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Procaine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Procaine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Procaine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Procaine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Procaine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Procaine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Procaine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Procaine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Procaine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Procaine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Procaine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Procaine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Procaine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Procaine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Procaine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Procaine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Procaine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Procaine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Procaine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Procaine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Procaine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Procaine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Procaine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Procaine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Procaine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Procaine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Procaine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Procaine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Procaine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Procaine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Procaine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Procaine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Procaine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Procaine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Procaine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Procaine Sales Volume, (2025-2030) & (K Units)
    Table 57. Eli Lilly and Company Company Information
    Table 58. Eli Lilly and Company Introduction and Business Overview
    Table 59. Eli Lilly and Company Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Eli Lilly and Company Procaine Product Offerings
    Table 61. Eli Lilly and Company Recent Development
    Table 62. Consolidated Pharmaceutical Company Information
    Table 63. Consolidated Pharmaceutical Introduction and Business Overview
    Table 64. Consolidated Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Consolidated Pharmaceutical Procaine Product Offerings
    Table 66. Consolidated Pharmaceutical Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Procaine Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Bristol-Myers Squibb Company Information
    Table 73. Bristol-Myers Squibb Introduction and Business Overview
    Table 74. Bristol-Myers Squibb Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Bristol-Myers Squibb Procaine Product Offerings
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Bel Mar Laboratories Company Information
    Table 78. Bel Mar Laboratories Introduction and Business Overview
    Table 79. Bel Mar Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Bel Mar Laboratories Procaine Product Offerings
    Table 81. Bel Mar Laboratories Recent Development
    Table 82. Elkins Sinn Company Information
    Table 83. Elkins Sinn Introduction and Business Overview
    Table 84. Elkins Sinn Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Elkins Sinn Procaine Product Offerings
    Table 86. Elkins Sinn Recent Development
    Table 87. Bayer Company Information
    Table 88. Bayer Introduction and Business Overview
    Table 89. Bayer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Bayer Procaine Product Offerings
    Table 91. Bayer Recent Development
    Table 92. Watson Laboratories Company Information
    Table 93. Watson Laboratories Introduction and Business Overview
    Table 94. Watson Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Watson Laboratories Procaine Product Offerings
    Table 96. Watson Laboratories Recent Development
    Table 97. RNP Pharmaceuticals Company Information
    Table 98. RNP Pharmaceuticals Introduction and Business Overview
    Table 99. RNP Pharmaceuticals Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. RNP Pharmaceuticals Procaine Product Offerings
    Table 101. RNP Pharmaceuticals Recent Development
    Table 102. Tbilchempharma Company Information
    Table 103. Tbilchempharma Introduction and Business Overview
    Table 104. Tbilchempharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Tbilchempharma Procaine Product Offerings
    Table 106. Tbilchempharma Recent Development
    Table 107. SÜDmedica Gmbh Company Information
    Table 108. SÜDmedica Gmbh Introduction and Business Overview
    Table 109. SÜDmedica Gmbh Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. SÜDmedica Gmbh Procaine Product Offerings
    Table 111. SÜDmedica Gmbh Recent Development
    Table 112. Grindeks Company Information
    Table 113. Grindeks Introduction and Business Overview
    Table 114. Grindeks Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Grindeks Procaine Product Offerings
    Table 116. Grindeks Recent Development
    Table 117. Towa Yakuhin Company Information
    Table 118. Towa Yakuhin Introduction and Business Overview
    Table 119. Towa Yakuhin Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Towa Yakuhin Procaine Product Offerings
    Table 121. Towa Yakuhin Recent Development
    Table 122. Hikari Seiyaku Company Information
    Table 123. Hikari Seiyaku Introduction and Business Overview
    Table 124. Hikari Seiyaku Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Hikari Seiyaku Procaine Product Offerings
    Table 126. Hikari Seiyaku Recent Development
    Table 127. Köhler-Pharma Company Information
    Table 128. Köhler-Pharma Introduction and Business Overview
    Table 129. Köhler-Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Köhler-Pharma Procaine Product Offerings
    Table 131. Köhler-Pharma Recent Development
    Table 132. Ardeapharma Company Information
    Table 133. Ardeapharma Introduction and Business Overview
    Table 134. Ardeapharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Ardeapharma Procaine Product Offerings
    Table 136. Ardeapharma Recent Development
    Table 137. Stada Company Information
    Table 138. Stada Introduction and Business Overview
    Table 139. Stada Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Stada Procaine Product Offerings
    Table 141. Stada Recent Development
    Table 142. Fuso Pharmaceutical Company Information
    Table 143. Fuso Pharmaceutical Introduction and Business Overview
    Table 144. Fuso Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Fuso Pharmaceutical Procaine Product Offerings
    Table 146. Fuso Pharmaceutical Recent Development
    Table 147. Hevert-Arzneimittel Company Information
    Table 148. Hevert-Arzneimittel Introduction and Business Overview
    Table 149. Hevert-Arzneimittel Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Hevert-Arzneimittel Procaine Product Offerings
    Table 151. Hevert-Arzneimittel Recent Development
    Table 152. Teofarma Company Information
    Table 153. Teofarma Introduction and Business Overview
    Table 154. Teofarma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Teofarma Procaine Product Offerings
    Table 156. Teofarma Recent Development
    Table 157. Richter Pharma Company Information
    Table 158. Richter Pharma Introduction and Business Overview
    Table 159. Richter Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Richter Pharma Procaine Product Offerings
    Table 161. Richter Pharma Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Procaine Downstream Customers
    Table 165. Procaine Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Procaine Product Picture
    Figure 2. Global Procaine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Procaine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Procaine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Procaine Report Years Considered
    Figure 7. Global Procaine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Procaine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Procaine Revenue in 2023
    Figure 10. Procaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Injection Picture
    Figure 12. Powder Picture
    Figure 13. Global Procaine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Procaine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Procaine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Procaine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Procaine Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drug Store
    Figure 20. Product Picture of On-line
    Figure 21. Global Procaine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Procaine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Procaine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Procaine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Procaine Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Procaine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Procaine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Procaine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Procaine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Procaine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Procaine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Procaine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Procaine Sales Volume (%), (2019-2030)
    Figure 38. United States Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Procaine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Procaine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Procaine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Procaine Industrial Chain
    Figure 60. Procaine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9U15196
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-14K1494
Thu Dec 12 00:00:00 UTC 2024

Add to Cart